Childhood vaccination schedule

Template:Vaccination schedule Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Childhood vaccination schedule

The following table summarizes the vaccination schedule for Adolescents Aged 18 Years or Younger based on CDC 2017 recommendation.

Vaccine	Birth	1 mo	2 mos	4 mos	6 mos	9 mos	12 mos	15 mos	18 mos	19-23 mos	2-3 yrs	4-6 yrs	7-10 yrs	11-12 yrs	13-15 yrs	16 yrs	17-18 yrs
Hepatitis B1 (Hep B)	1st dose	2nd dose			3rd dose
Rotavirus2 (RV) RV1 (2-dose series); RV5 (3-dose series)			1st dose	2nd dose	See footnote 2
Diphtheria, tetanus, & acellular pertussis3 (DTaP: <7 yrs)			1st dose	2nd dose	3rd dose			4th dose				5th dose
Haemophilus influenzae type b4 (Hib)			1st dose	2nd dose	See footnote 4		3rd or 4th dose, See footnote 4
Pneumococcal conjugate5 (PCV13)			1st dose	2nd dose	3rd dose		4th dose
Inactivated poliovirus6 (IPV: <18 yrs)			1st dose	2nd dose	3rd dose							4th dose
Influenza7 (IIV)					Annual vaccination (IIV) 1 or 2 doses									Annual vaccination (IIV) 1 dose only
Measles, mumps, rubella8 (MMR)					See footnote 8		1st dose					2nd dose
Varicella9 (VAR)							1st dose					2nd dose
Hepatitis A10 (Hep A)							2-dose series, See footnote 10
Meningococcal11 (Hib-MenCY >6 weeks; MenACWY-D >9 mos; MenACWY-CRM ≥2 mos)			See footnote 11											1st dose		2nd dose
Tetanus, diphtheria, & acellular pertussis12 (Tdap: >7 yrs)														Tdap
Human papillomavirus13 (HPV)																See footnote 13
Meningococcal B11													See footnote 11
Pneumococcal polysaccharide5 (PPSV23)											See footnote 5

	Range of recommended ages for all children
	Range of recommended ages for catch-up immunization
	No recommendation
	Range of recommended ages for certain high-risk groups

Catch-up immunization

Catch-up immunization schedule for persons aged 4 months through 18 years who start late or who are more than 1 month behind.
The table below provides catch-up schedules and minimum intervals between doses for children whose vaccinations have been delayed. A vaccine series does not need to be restarted, regardless of the time that has elapsed between doses. Use the section appropriate for the child’s age. Always use this table in conjunction with above table and the footnotes that follow.

Children age 4 months through 6 years
Vaccine	Minimum Age for Dose 1	Minimum Interval Between Doses
		Dose 1 to Dose 2	Dose 2 to Dose 3	Dose 3 to Dose 4	Dose 4 to Dose 5
Hepatitis B1	Birth	4 weeks	8 weeks and at least 16 weeks after first dose. Minimum age for the final dose is 24 weeks.
Rotavirus2	6 weeks	4 weeks	4 weeks2
Diphtheria, tetanus, and acellular pertussis3	6 weeks	4 weeks	4 weeks	6 months	6 months3
Haemophilus influenzae type b4	6 weeks	4 weeks if first dose was administered before the 1st birthday. 8 weeks (as final dose) if first dose was administered at age 12 through 14 months. No further doses needed if first dose was administered at age 15 months or older.	4 weeks4 If current age is younger than 12 months and first dose was administered at younger than age 7 months, and at least 1 previous dose was PRP-T (ActHib, Pentacel, Hiberix) or unknown. 8 weeks and age 12 through 59 months (as final dose)4 If current age is younger than 12 months and first dose was administered at age 7 through 11 months; OR If current age is 12 through 59 months and first dose was administered before the 1st birthday, and second dose administered at younger than 15 months; OR If both doses were PRP-OMP (PedvaxHIB; Comvax) and were administered before the 1st birthday. No further doses needed if previous dose was administered at age 15 months or older.	8 weeks (as final dose) This dose only necessary for children age 12 through 59 months who received 3 doses before the 1st birthday.
Pneumococcal5	6 weeks	4 weeks if first dose administered before the 1st birthday. 8 weeks (as final dose for healthy children) if first dose was administered at the 1st birthday or after. No further doses needed for healthy children if first dose was administered at age 24 months or older.	4 weeks if current age is younger than 12 months and previous dose given at <7 months old. 8 weeks (as final dose for healthy children) if previous dose given between 7-11 months (wait until at least 12 months old); OR if current age is 12 months or older and at least 1 dose was given before age 12 months. No further doses needed for healthy children if previous dose administered at age 24 months or older.	8 weeks (as final dose) This dose only necessary for children aged 12 through 59 months who received 3 doses before age 12 months or for children at high risk who received 3 doses at any age.
Inactivated poliovirus6	6 weeks	4 weeks6	4 weeks6	6 months6 (minimum age 4 years for final dose).
Measles, mumps, rubella8	12 months	4 weeks
Varicella9	12 months	3 months
Hepatitis A10	12 months	6 months
Meningococcal11 (Hib-MenCY ≥6 weeks; MenACWY-D ≥9 mos; MenACWY-CRM ≥2 mos)	6 weeks	8 weeks11	See footnote 11	See footnote 11

Children and adolescents age 7 through 18 years
Vaccine	Minimum Age for Dose 1	Minimum Interval Between Doses
		Dose 1 to Dose 2	Dose 2 to Dose 3	Dose 3 to Dose 4	Dose 4 to Dose 5
Meningococcal11 (MenACWY-D ≥9 mos; MenACWY-CRM ≥2 mos)	Not Applicable (N/A)	8 weeks11
Tetanus, diphtheria; Tetanus, diphtheria, and acellular pertussis12	7 years12	4 weeks	4 weeks if first dose of DTaP/DT was administered before the 1st birthday. 6 months (as final dose) if first dose of DTaP/DT or Tdap/Td was administered at or after the 1st birthday	6 months If first dose of DTaP/DT was administered before the 1st birthday.
Human papillomavirus13	9 years	Routine dosing intervals are recommended.13
Hepatitis A10	N/A	6 months
Hepatitis B1	N/A	4 weeks	8 weeks and at least 16 weeks after first dose.
Inactivated poliovirus6	N/A	4 weeks	4 weeks6	6 months6
Measles, mumps, rubella8	N/A	4 weeks
Varicella9	N/A	3 months if younger than age 13 years. 4 weeks if age 13 years or older.

Specific conditions

Vaccines that might be indicated for children and adolescents aged 18 years or younger based on medical indications.

VACCINE	Pregnancy	Immunocompromised status (excluding HIV infection)	HIV infection CD4+ count (cells/μL)		Kidney failure, endstage renal disease, on hemodialysis	Heart disease, chronic lung disease	CSF leaks/ cochlear implants	Asplenia and persistent complement component deficiencies	Chronic liver disease	Diabetes
			<15% of total CD4 cell count	≥15% of total CD4 cell count
Hepatitis B1
Rotavirus2
		SCID
Diphtheria, tetanus, & acellular pertussis3 (DTaP)
Haemophilus influenzae type b4
Pneumococcal conjugate5
Inactivated poliovirus6
Influenza7
Measles, mumps, rubella8
Varicella9
Hepatitis A10
Meningococcal ACWY11
Tetanus, diphtheria, & acellular pertussis12 (Tdap)
Human papillomavirus13
Meningococcal B11
Pneumococcal polysaccharide5

	Vaccination according to the routine schedule recommended
	Recommended for persons with an additional risk factor for which the vaccine would be indicated
	Vaccination is recommended, and additional doses may be necessary based on medical condition. See footnotes.
	No recommendation
	Contraindicated
	Precaution for vaccination

Footnotes

Hepatitis B (HepB) vaccine (Minimum age: birth)	Routine vaccination		Catch-up vaccination
	At birth	Doses following the birth dose
Hepatitis B (HepB) vaccine (Minimum age: birth)	Administer monovalent HepB vaccine to all newborns within 24 hours of birth. For infants born to hepatitis B surface antigen (HBsAg)- positive mothers, administer HepB vaccine and 0.5 mL of hepatitis B immune globulin (HBIG) within 12 hours of birth. These infants should be tested for HBsAg and antibody to HBsAg (anti-HBs) at age 9 through 12 months (preferably at the next well-child visit) or 1 to 2 months after completion of the HepB series if the series was delayed. If mother’s HBsAg status is unknown, within 12 hours of birth, administer HepB vaccine regardless of birth weight. For infants weighing less than 2,000 grams, administer HBIG in addition to HepB vaccine within 12 hours of birth. Determine mother’s HBsAg status as soon as possible and, if mother is HBsAg-positive, also administer HBIG to infants weighing 2,000 grams or more as soon as possible, but no later than age 7 days.	The second dose should be administered at age 1 or 2 months. Monovalent HepB vaccine should be used for doses administered before age 6 weeks. Infants who did not receive a birth dose should receive 3 doses of a HepB-containing vaccine on a schedule of 0, 1 to 2 months, and 6 months, starting as soon as feasible. Administer the second dose 1 to 2 months after the first dose (minimum interval of 4 weeks); administer the third dose at least 8 weeks after the second dose AND at least 16 weeks after the first dose. The final (third or fourth) dose in the Hep B vaccine series should be administered no earlier than age 24 weeks. Administration of a total of 4 doses of HepB vaccine is permitted when a combination vaccine containing HepB is administered after the birth dose.	Unvaccinated persons should complete a 3-dose series. A 2-dose series (doses separated by at least 4 months) of adult formulation Recombivax HB is licensed for use in children aged 11 through 15 years.
Rotavirus (RV) vaccines. (Minimum age: 6 weeks for both RV1 [Rotarix] and RV5 [RotaTeq])	Administer a series of RV vaccine to all infants as follows: If Rotarix is used, administer a 2-dose series at ages 2 and 4 months. If RotaTeq is used, administer a 3-dose series at ages 2, 4, and 6 months. If any dose in the series was RotaTeq or vaccine product is unknown for any dose in the series, a total of 3 doses of RV vaccine should be administered.		The maximum age for the first dose in the series is 14 weeks, 6 days; vaccination should not be initiated for infants aged 15 weeks, 0 days, or older. The maximum age for the final dose in the series is 8 months, 0 days.
Diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine. (Minimum age: 6 weeks. Exception: DTaPIPV [Kinrix, Quadracel]: 4 years)	Administer a 5-dose series of DTaP vaccine at ages 2, 4, 6, 15 through 18 months, and 4 through 6 years. The fourth dose may be administered as early as age 12 months, provided at least 6 months have elapsed since the third dose. Inadvertent administration of fourth DTaP dose early: If the fourth dose of DTaP was administered at least 4 months after the third dose of DTaP and the child was 12 months of age or older, it does not need to be repeated.		The fifth dose of DTaP vaccine is not necessary if the fourth dose was administered at age 4 years or older.

See also

• Flu vaccine
• H5N1 clinical trials

External links

• National Center for Immunization and Respiratory Diseases. "CDC National Immunization Program". CDC. Retrieved 2006-09-18.
• "MMR vaccine and the autism epidemic: In a compulsory inoculation program, it is the responsibility of the developers, promoters and enforcers to prove safety and efficacy". MMR vaccine and the autism epidemic. InformedChoice.info. Retrieved 2006-09-18.
• National Health Service of UK. "UK Immunisation Schedule and Information". NHS. Retrieved 2006-11-03.